Clinical trial
Autoimmunity in Retinitis Pigmentosa
NCT00433277 · Semmelweis University, Other · Unknown status
Key facts
| NCT number | NCT00433277 |
|---|---|
| Title | Autoimmunity in Retinitis Pigmentosa |
| Lead sponsor | Semmelweis University, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Retinitis Pigmentosa |
| Intervention type | Drug |
| Interventions | twice-daily dosage with 0.5% cyclosporine-A eyedrops |
| First posted | Feb 9, 2007 |
| Last update posted | Feb 9, 2007 |
| Countries | Hungary |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: